ANLON HEALTHCARE LIMITED vs CIPLA LTD

A side-by-side comparison of ANLON HEALTHCARE LIMITED (AHCL) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

ANLON HEALTHCARE LIMITED and CIPLA LTD are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

28.88
P/E ratio
29.54
3.56
P/B ratio
3.42
0.00%
Dividend yield
0.90%
₹0.51
EPS
₹48.02

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

25.51%
Return on equity
11.60%
25.00%
Return on capital
15.00%
27.00%
EBITDA margin
21.00%
17.50%
Net margin
13.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

15.02%
Revenue CAGR (3Y)
7.37%
69.25%
Profit CAGR (3Y)
10.88%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹793 Cr
Market cap
₹1.15L Cr
₹120 Cr
Revenue
₹28,163 Cr
₹21 Cr
Net profit
₹3,862 Cr
0.22
Debt / equity
0.02
ANLON HEALTHCARE LIMITED
  • + ["Company has reduced debt.", "Company is expected to give good quarter", "Company has delivered good profit growth of 36.4% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 27.6%"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 215 days."]
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
ANLON HEALTHCARE LIMITED full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ANLON HEALTHCARE LIMITED vs CIPLA LTD: Share Price, Valuation & Which to Buy | DocStoX